vanadates has been researched along with Colonic Neoplasms in 13 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (7.69) | 18.7374 |
1990's | 5 (38.46) | 18.2507 |
2000's | 7 (53.85) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azevedo, I; Calhau, C; HipĆ³lito-Reis, C; Martel, F | 1 |
Banerjee, P; Chakraborty, T; Chatterjee, M; Hemalatha, P; Kanna, PS; Mahendrakumar, CB | 1 |
Bertagnolli, MM; Carothers, AM; Moran, AE; Redston, M; Weyant, MJ | 1 |
Frolkis, M; Gong, X; Ku, NO; Nakamichi, I; Omary, MB; Pytela, R; Tao, GZ; Wang, J; Zhu, W | 1 |
Blay, J; Hoskin, DW; Richard, CL; Tan, EY; Zhang, H | 1 |
Heruth, DP; Leyva, A; Rothberg, PG; Wetmore, LA | 1 |
Capolongo, L; Ciomei, M; Geroni, C; Grandi, M; Melegaro, G; Pastori, W; Pennella, G | 1 |
Beauchemin, N; Chow, B; Daniels, E; Kunath, T; Robitaille, J; Turbide, C; Veillette, A | 1 |
Boyd, D; Gum, R; Lengyel, E; Simon, C; Wang, H; Wang, Y | 1 |
Arigoni, F; Curchod, ML; Hooft van Huijsduijnen, R; Pasquali, C; Vilbois, F | 1 |
Kim, K; Lee, KY | 1 |
Kovach, JS; Schaid, DJ; Svingen, PA | 1 |
Bolen, JB; DeSeau, V; Rosen, N | 1 |
13 other study(ies) available for vanadates and Colonic Neoplasms
Article | Year |
---|---|
Modulation of uptake of organic cationic drugs in cultured human colon adenocarcinoma Caco-2 cells by an ecto-alkaline phosphatase activity.
Topics: Adenocarcinoma; Alkaline Phosphatase; Antioxidants; Ascorbic Acid; Caco-2 Cells; Cations; Cell Membrane; Colonic Neoplasms; Dose-Response Relationship, Drug; Humans; Phosphoric Monoester Hydrolases; Protein Transport; Tretinoin; Tumor Cells, Cultured; Up-Regulation; Vanadates | 2002 |
Effect of vanadium on colonic aberrant crypt foci induced in rats by 1,2 dimethyl hydrazine.
Topics: 1,2-Dimethylhydrazine; Adenoma; Animals; Carcinogens; Carcinoma; Colon; Colonic Neoplasms; Cytochrome P-450 Enzyme System; Glutathione Transferase; Male; Precancerous Conditions; Proliferating Cell Nuclear Antigen; Rats; Rats, Sprague-Dawley; Vanadates | 2003 |
Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.
Topics: Abietanes; Adenoma; Animals; beta Catenin; Cadherins; Cell Adhesion; Cell Membrane; Colonic Neoplasms; Cytoskeletal Proteins; Enterocytes; Female; Intestine, Small; Mice; Mice, Inbred C57BL; Phenanthrenes; Phosphorylation; Rosmarinus; Trans-Activators; Tyrosine; Vanadates | 2005 |
Bispecific and human disease-related anti-keratin rabbit monoclonal antibodies.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Brain; Brain Chemistry; Cell Line; Colonic Neoplasms; Cricetinae; Enzyme Inhibitors; Epitopes; HT29 Cells; Humans; Immunoblotting; Immunohistochemistry; Keratin-18; Keratin-8; Keratins; Kidney; Liver; Liver Diseases; Mice; Mutation; Okadaic Acid; Phosphorylation; Rabbits; Serine; Stomach Neoplasms; Transfection; Vaccination; Vanadates | 2006 |
Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatase(s) and reducing ERK1/2 activity via a novel pathway.
Topics: Adenosine; Colonic Neoplasms; Dipeptidyl Peptidase 4; Down-Regulation; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Protein Kinase C; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; RNA, Messenger; Signal Transduction; Vanadates; Vanadium Compounds | 2006 |
Influence of protein tyrosine phosphorylation on the expression of the c-myc oncogene in cancer of the large bowel.
Topics: Benzoquinones; Cell Count; Cell Line; Colonic Neoplasms; Cycloheximide; Dose-Response Relationship, Drug; Gene Expression Regulation, Neoplastic; Genes, myc; Genistein; Half-Life; Humans; Isoflavones; Lactams, Macrocyclic; Novobiocin; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Quinones; RNA, Messenger; Topoisomerase II Inhibitors; Tyrosine; Vanadates | 1995 |
Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Distamycins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Enzyme Inhibitors; Humans; Leukemia L1210; Mice; Neoplasm Proteins; Nitrogen Mustard Compounds; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Sensitivity and Specificity; Tumor Cells, Cultured; Tyrosine; Vanadates | 1995 |
Association of biliary glycoprotein with protein tyrosine phosphatase SHP-1 in malignant colon epithelial cells.
Topics: Amino Acid Sequence; Animals; Carcinoembryonic Antigen; Cell Adhesion Molecules; Colonic Neoplasms; Glycoproteins; Intracellular Signaling Peptides and Proteins; Mice; Molecular Sequence Data; Phosphorylation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Protein Tyrosine Phosphatases; SH2 Domain-Containing Protein Tyrosine Phosphatases; src Homology Domains; Tumor Cells, Cultured; Tyrosine; Vanadates | 1997 |
Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade.
Topics: Calcium-Calmodulin-Dependent Protein Kinases; Cell Cycle Proteins; Colonic Neoplasms; Dual Specificity Phosphatase 1; Enzyme Inhibitors; Flavonoids; Genes, ras; Immediate-Early Proteins; Laminin; MAP Kinase Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinase Kinases; Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Plasminogen Activators; Protein Phosphatase 1; Protein Serine-Threonine Kinases; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-raf; Receptors, Cell Surface; Receptors, Urokinase Plasminogen Activator; Signal Transduction; Time Factors; Tumor Cells, Cultured; Vanadates | 1997 |
Mapping and identification of protein-protein interactions by two-dimensional far-Western immunoblotting.
Topics: Adenocarcinoma; Blotting, Western; Colonic Neoplasms; Electrophoresis, Polyacrylamide Gel; Humans; Mass Spectrometry; Protein Tyrosine Phosphatases; Substrate Specificity; Tubulin; Tumor Cells, Cultured; Vanadates | 2000 |
Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Topics: 3T3 Cells; Animals; beta Catenin; Biological Transport; Cell Communication; Cell Membrane; Colonic Neoplasms; Cyclin D1; Cytoplasm; Cytoskeletal Proteins; DNA-Binding Proteins; Enzyme Inhibitors; Gene Expression; Humans; Luciferases; Lymphoid Enhancer-Binding Factor 1; Mice; Phosphorylation; Protein Tyrosine Phosphatases; Trans-Activators; Transcription Factors; Tumor Cells, Cultured; Tyrosine; Vanadates | 2001 |
Levamisole potentiation of fluorouracil antiproliferative activity mimicked by orthovanadate, an inhibitor of tyrosine phosphatase.
Topics: Breast Neoplasms; Colonic Neoplasms; Drug Synergism; Ethers, Cyclic; Fluorouracil; Humans; Levamisole; Melanoma; Okadaic Acid; Phosphoric Monoester Hydrolases; Skin Neoplasms; Tumor Cells, Cultured; Tumor Stem Cell Assay; Vanadates | 1992 |
Analysis of pp60c-src tyrosine kinase activity and phosphotyrosyl phosphatase activity in human colon carcinoma and normal human colon mucosal cells.
Topics: Adenocarcinoma; Buffers; Cells, Cultured; Colonic Neoplasms; Humans; Immunologic Techniques; Intestinal Mucosa; Oncogene Protein pp60(v-src); Peptide Mapping; Phosphoprotein Phosphatases; Phosphotyrosine; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Retroviridae Proteins; Tyrosine; Vanadates | 1987 |